Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4068115
Max Phase: Preclinical
Molecular Formula: C30H37ClO9
Molecular Weight: 577.07
Molecule Type: Small molecule
Associated Items:
ID: ALA4068115
Max Phase: Preclinical
Molecular Formula: C30H37ClO9
Molecular Weight: 577.07
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)[C@]1(O)CC[C@@]2(O)[C@]1(C)[C@H](OC(=O)c1ccc(O)cc1)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)CC3=CC[C@]12O
Standard InChI: InChI=1S/C30H37ClO9/c1-17(32)28(36)12-13-30(38)27(28,3)23(40-25(35)18-4-6-20(33)7-5-18)15-22-26(2)10-9-21(39-24(34)16-31)14-19(26)8-11-29(22,30)37/h4-8,21-23,33,36-38H,9-16H2,1-3H3/t21-,22+,23+,26-,27+,28+,29-,30+/m0/s1
Standard InChI Key: UCHSQXQNUUFFLM-CZTKLRHSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 577.07 | Molecular Weight (Monoisotopic): 576.2126 | AlogP: 3.19 | #Rotatable Bonds: 5 |
Polar Surface Area: 150.59 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.50 | CX Basic pKa: | CX LogP: 2.69 | CX LogD: 2.66 |
Aromatic Rings: 1 | Heavy Atoms: 40 | QED Weighted: 0.24 | Np Likeness Score: 2.31 |
1. Huang LJ, Chen SR, Yuan CM, Gu W, Guo BJ, Wang YT, Wang Y, Hao XJ.. (2017) C21-steroidal pregnane sapogenins and their derivatives as anti-inflammatory agents., 25 (13): [PMID:28506585] [10.1016/j.bmc.2017.04.045] |
Source(1):